| | Basic and Translational Investigations Epidemiology and Cancer Control Descriptive epidemiology of vestibular schwannomas Jennifer M. Propp, Bridget J. McCarthy, Faith G. Davis, and Susan Preston-Martin Neuro-oncol. 2006 January; 8(1): 1–11. doi: 10.1215/S1522851704001097.PMCID: PMC1871924 Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area Margaret Wrensch, Terri Rice, Rei Miike, Alex McMillan, Kathleen R. Lamborn, Kenneth Aldape, and Michael D. Prados Neuro-oncol. 2006 January; 8(1): 12–26. doi: 10.1215/S1522851705000268.PMCID: PMC1871921 Temporal trends in incidence of primary brain tumors in the United States, 1985–1999 Sara Hoffman, Jennifer M. Propp, and Bridget J. McCarthy Neuro-oncol. 2006 January; 8(1): 27–37. doi: 10.1215/S1522851705000323.PMCID: PMC1871920 Clinical Investigations Clinical Therapy Trials Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas Gaurav D. Shah, Santosh Kesari, Ronghui Xu, Tracy T. Batchelor, Alison M. O’Neill, Fred H. Hochberg, Brenda Levy, Joanna Bradshaw, and Patrick Y. Wen Neuro-oncol. 2006 January; 8(1): 38–46. doi: 10.1215/S1522851705000529.PMCID: PMC1871928 Clinical Therapy Trials-Radiation Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021 H. Ian Robins, M. Won, Wendy F. Seiferheld, Christopher J. Schultz, Ali K. Choucair, David G. Brachman, William F. Demas, and Minesh P. Mehta Neuro-oncol. 2006 January; 8(1): 47–52. doi: 10.1215/S1522851705000311.PMCID: PMC1871929 Clinical Therapy Trials-Drug Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors David S. Ziegler, Richard J. Cohn, Geoffrey McCowage, Frank Alvaro, Cecilia Oswald, Robert Mrongovius, Les White, and for the Australian and New Zealand Children’s Cancer Study Group Neuro-oncol. 2006 January; 8(1): 53–59. doi: 10.1215/S1522851705000463.PMCID: PMC1871918 Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma Alexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, Laurent Capelle, Anthony Behin, Annick Tibi, Nadine Martin-Duverneuil, Marc Sanson, Lucette Lacomblez, Sophie Taillibert, Louis Puybasset, Remy Van Effenterre, Jean-Yves Delattre, and Antoine F. Carpentier Neuro-oncol. 2006 January; 8(1): 60–66. doi: 10.1215/S1522851705000475.PMCID: PMC1871923 Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma Michael D. Prados, Kathleen R. Lamborn, Susan Chang, Eric Burton, Nicholas Butowski, Mary Malec, Ami Kapadia, Jane Rabbitt, Margaretta S. Page, Ann Fedoroff, Dong Xie, and Sean K. Kelley Neuro-oncol. 2006 January; 8(1): 67–78. doi: 10.1215/S1522851705000451.PMCID: PMC1871925 Case Study Neuropathology Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: Case study Jeffrey C. Allen, Alexander R. Judkins, Marc K. Rosenblum, and Jaclyn A. Biegel Neuro-oncol. 2006 January; 8(1): 79–82. PMCID: PMC1871926 Book Reviews Neurosurgery of Complex Vascular Lesions and Tumors Neuro-oncol. 2006 January; 8(1): 83–84. doi: 10.1215/S1522851705200029.PMCID: PMC1871919 Neuro-oncol. 2006 January; 8(1): 85–86. doi: 10.1215/S1522851704200060.PMCID: PMC1871927 Society News and Announcements SOCIETY NEWS AND ANNOUNCEMENTS Neuro-oncol. 2006 January; 8(1): 87–88. doi: 10.1215/S1522851705200248.PMCID: PMC1871922 |